ReviewJournal of clinical medicine2023

The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma.

Maxime Borgeaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.